Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

shutterstock_168864905

Ipsen shells out $1.31bn to acquire rare disease specialist Clementia Pharmaceuticals

February 25, 2019 Sales and Marketing Clementia pharmaceuticals, acquisition, ipsen, rare disease

In a bid to boost its rare disease portfolio prospects, Ipsen has revealed its intention to acquire Clementia Pharmaceuticals, with …
News
cocaine

UK launches drug testing service for illicit drugs

February 25, 2019 Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs

The UK Home Office have licensed a drug-checking service for users of illicit substances. The yearlong pilot project, run by …
News
johnson_and_johnson_jj

Missouri Supreme Court ruling could help J&J in talc cases

February 25, 2019 Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc

The Missouri Supreme Court has ruled that the practice of combining two or more cases in order to allow courts …
News

Roche set to acquire Spark Therapeutics in $4.8 billion deal

February 25, 2019 Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma

Roche is set to fully acquire gene therapy Spark Therapeutics after entering into a definitive merger agreement, after the Boards …
News
iran

Iran ready to export medicines to Venezuela

February 25, 2019 Sales and Marketing FDA, Iran, Venezuela, biotech, global, pharma

The chairman of the Iranian Food and Drug Administration (FDA) Mehdi Pirsalehi, has said that Iran is ready to export …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
News
facilities_lg06

Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market

February 21, 2019 Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior

Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …
News

Teva settles ‘pay-to-delay’ case with FTC

February 21, 2019 Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly

Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …
News

Philippines’ FDA halts sales of Sanofi’s dengue vaccine

February 19, 2019 Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …
News
screen_shot_2019-01-29_at_15

Beating the flu

February 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus

On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …
Feature

Astellas’ Xtandi “significantly improves” progression-free survival in advanced hormone-sensitive prostate cancer

February 18, 2019 Research and Development, Sales and Marketing Astellas, Cancer, Xtandi, pharma, prostate cancer

Japanese pharma firm Astellas has lifted the curtain on new data for its androgen receptor signalling inhibitor Xtandi (enzalutamide), when …
News

Smoking may limit immune system’s ability to fight cancer, study shows

February 18, 2019 Sales and Marketing Cancer, cancer research, immune system, immunology, melanoma, oncology, smoking

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research. The …
News
shutterstock_38078521

Bavencio+Inlyta combo boosts progression-free survival in advanced kidney cancer

February 18, 2019 Research and Development, Sales and Marketing Bavencio, Cancer, Kidney cancer, Merck KGaA, Pfizer, inlyta, pharma

New interim data for the combination of Pfizer’s Bavencio (avelumab) and Merck KGaA’s Inlyta (axitinib) have been released, showing that …
News

Researchers activate gene to reverse depression in mice

February 18, 2019 Sales and Marketing SIRT1, depression, genetics, mental health

Scientists at the Medical College of Georgia at Augusta University were able to directly activate a gene associated with depression …
News
merckwindow_web

MSD’s Keytruda combo therapy significantly improves survival in advanced renal cell carcinoma

February 18, 2019 Sales and Marketing Cancer, MSD, Merck Sutent, Pfizer, inlyta, keytruda, oncology, rcc, renal cell carcinoma

Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced renal …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026